Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has actually axed its own once-monthly dual GLP-1/ GIP receptor agonist, finishing (PD...

Daiichi pays for Merck $170M to develop bronchi cancer T-cell engager deal

.Merck &amp Co. has actually promptly redeemed some of the expenses of its own Weapon Therapeutics b...

BioMarin stops preclinical genetics therapy for heart disease

.After BioMarin conducted a spring season well-maintained of its own pipe in April, the provider has...

Eisai plants molecular glue SEED with $1.5 B biobucks handle

.Major Pharmas stay stuck to the suggestion of molecular adhesive degraders. The most recent provide...

Life science credit scores company introduces with $600M

.A new international life science credit scores company, dubbed Symbiotic Funds, has actually increa...

BMS trenches TIGIT, bowing out $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing one more large bet from the Caforio period, terminating a pa...

Nuvation halts BET inhibitor after considering phase 1 information

.After taking a look at stage 1 data, Nuvation Biography has decided to halt work with its single to...

' Clinical instinct' led FDA experts to support Zevra's uncommon health condition med

.Zevra Therapies' rare health condition medication seems to become on the path to approval this fall...

Pfizer takes $230M struck after axing fell short DMD gene therapy

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene treatment failing has actually blown a $230...

AC Immune sees 'landmark' possible in Alzheimer's medication data

.After greater than 20 years of work on neurodegenerative diseases, Swiss biotech a/c Invulnerable c...